Annals of Emergency Medicine
Volume 45, Issue 6 , Pages 595-602 , June 2005

Crotalidae Polyvalent Immune Fab (Ovine) Antivenom Is Effective in the Neutralization of South American Viperidae Venoms in a Murine Model

Received 30 April 2004 ,Revised 25 August 2004 ,Accepted 30 August 2004.

References 

  1. Parrish HM. Incidence of treated snakebites in the United States. Public Health Rep. 1966;81:269–276
  2. Offerman SR, Bush SP, Moynihan JA, et al. Crotaline Fab antivenom for the treatment of children with rattlesnake envenomation. Pediatrics. 2002;110:968–971
  3. Minton SA. Non-native venomous snakes in the United States. Wild Environ Med. 1996;7:297–303
  4. Litovitz TL, Klein-Schwartz W, White S, et al. 2000 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2001;19:337–395
  5. Litovitz TL, Klein-Schwartz W, Rodgers GC, et al. 2001 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2002;20:391–452
  6. Watson WA, Litovitz TL, Rodgers GC, et al. 2002 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2003;21:352–421
  7. Consroe P, Egan NB, Russell FE, et al. Comparison of a new ovine antigen binding fragment (Fab) antivenin for United States Crotalidae with the commercial antivenin for protection against venom-induced lethality in mice. Am J Trop Med Hyg. 1995;53:507–510
  8. Dart RC, Seifert SA, Carroll L, et al. Affinity-purified, mixed monospecific crotalid antivenom ovine Fab for the treatment of crotalid venom poisoning. Ann Emerg Med. 1997;30:33–39
  9. Dart RC, Seifert SA, Boyer LV, et al. A randomized multicenter trial of Crotalinae polyvalent immune Fab (ovine) antivenom for the treatment of Crotalidae snakebite in the United States. Arch Intern Med. 2001;161:2030–2036
  10. Bush SP, Green SM, Moynihan JA, et al. Crotalidae Polyvalent Immune Fab (ovine) antivenom is efficacious for envenomations by southern Pacific rattlesnakes (Crotalus helleri). Ann Emerg Med. 2002;40:619–624
  11. Lavonas EJ, Gerardo CJ, O'Malley G, et al. Initial experience with Crotalidae Polyvalent Immune Fab (ovine) antivenom in the treatment of copperhead snakebite. Ann Emerg Med. 2004;43:200–206
  12. Wisniewski MS, Hill RE, Havey JM, et al. Australian tiger snake (Notechis scutatus) and Mexican coral snake (Micrurus species) antivenoms prevent death from United States coral snake (Micrurus fulvius fulvius) venom in a mouse model. J Toxicol Clin Toxicol. 2003;41:7–10
  13. Meier J, Theakston RD. Approximate LD50 determinations of snake venoms using eight to ten experimental animals. Toxicon. 1986;24:395–401
  14. Protherics, Inc . CroFab Crotalidae polyvalent immune Fab (ovine). [package insert] Nashville, TN: Protherics, Inc.; 2000;
  15. Zbinden GG, Flury-Roversi M. Significance of the LD50-test for the toxicological evaluation of chemical substances. Arch Toxicol. 1981;47:77–99
  16. Anderson SG, Gutierrez JM, Ownby CL. Comparison of the immunogenicity and antigenic composition of ten Central American snake venoms. Toxicon. 1993;31:1051–1059
  17. Gutierrez JM, Dos Santos MC, Furtado MF, et al. Biochemical and pharmacological similarities between the venoms of newborn Crotalus durissus durissus and adult Crotalus durissus terrificus rattlesnakes. Toxicon. 1991;29:1273–1277
  18. Clark RF, Williams SR, Nordt SP, et al. Successful treatment of crotalid-induced neurotoxicity with a new polyspecific crotalid Fab antivenom. Ann Emerg Med. 1997;30:54–57
  19. Bogarin G, Morais JF, Yamaguchi IK, et al. Neutralization of crotaline snake venoms from Central and South America by antivenoms produced in Brazil and Costa Rica. Toxicon. 2000;38:1429–1441
  20. Ownby CL, Colberg TR. Comparison of the immunogenicity and antigenicity composition of several venoms of snakes in the family Crotalidae. Toxicon. 1990;28:189–199
  21. Sanchez EE, Ramirez MS, Galan JA, et al. Cross reactivity of three antivenoms against North American snake venoms. Toxicon. 2003;41:315–320
  22. Arce V, Rojas E, Ownby CL, et al. Preclinical assessment of the ability of polyvalent (Crotalinae) and anticoral (Elapidae) antivenoms produced in Costa Rica to neutralize the venoms of North American snakes. Toxicon. 2003;41:851–860
  23. Schier JG, Weiner SW, Touger M, et al. Efficacy of Crotalidae Polyvalent Antivenin for treatment of hognosed viper (Porthidium nasutum) envenomation. Ann Emerg Med. 2003;41:391–395

 Author contributions: WHR and RFC conceived the study, design, and research. WHR and RFC obtained funding for the project. WHR coordinated data collection, analysis, and drafted the manuscript. WHR and RFC supervised the study and data collection. WHR, DAT, TCT, DPB, SDC, SRW, and FLC assisted with dosing trials, data collection, and modification of the study. WHR, DAT, SRW, and RFC participated in revision of the manuscript. WHR takes responsibility for the paper as a whole.Funding and support: Supported in part by an unrestricted grant from Altana, Inc. (Melville, NY) and antivenom donation from Protherics, Inc. (Nashville, TN).Presented at the Society of Academic Emergency Medicine annual meeting, Orlando, FL, May 2004.Reprints not available from the authors.

PII: S0196-0644(04)01324-1

doi: 10.1016/j.annemergmed.2004.08.038

Annals of Emergency Medicine
Volume 45, Issue 6 , Pages 595-602 , June 2005

Article Tools

* Image Usage & Resolution